SMTL ID : 4w2r.1 (1 other biounit)

Structure of Hs/AcPRC2 in complex with 5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-7-[(R)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.81 Å

Oligo State

hetero-1-1-1-mer

Ligands

7 x ZN: ZINC ION(Non-covalent)

ZN.1: 6 residues within 4Å: Chain A: C.420, H.422, C.427, C.431 Ligands: ZN.2, ZN.3 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.420, A:H.422, A:C.427, A:C.431 ZN.2: 5 residues within 4Å: Chain A: C.420, C.433, C.440, C.444 Ligands: ZN.1 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.420, A:C.433, A:C.440, A:C.444 ZN.3: 5 residues within 4Å: Chain A: C.427, C.440, C.446, C.450 Ligands: ZN.1 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.427, A:C.440, A:C.446, A:C.450 ZN.4: 6 residues within 4Å: Chain A: C.457, C.459, C.463, C.468, C.477 Ligands: ZN.5 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.457, A:C.459, A:C.463, A:C.468 ZN.5: 5 residues within 4Å: Chain A: C.463, C.477, C.485, C.498 Ligands: ZN.4 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.463, A:C.477, A:C.485, A:C.498 ZN.6: 4 residues within 4Å: Chain A: C.457, C.470, C.477, C.482 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.457, A:C.470, A:C.477, A:C.482 ZN.7: 4 residues within 4Å: Chain A: C.274, C.277, C.282, H.285 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.274, A:C.277, A:C.282, A:H.285

1 x CJD: 5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-7-[(R)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one(Non-covalent)

CJD.8: 13 residues within 4Å: Chain A: I.109, Y.111, G.520, W.521, Y.555, Y.558, C.560, F.562, T.575, R.582, F.583, A.584, N.585 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.109, A:Y.558, A:Y.558, A:F.562 Hydrogen bonds: A:Y.111, A:W.521, A:N.585 pi-Stacking: A:Y.111

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kung, P.P. et al., Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (R)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2H)-one (PF-06821497). J. Med. Chem. (2018)

Release Date

2017-12-27

Peptides

Enhancer of zeste 2 polycomb repressive complex 2 subunit: A
Polycomb protein EED: B
Polycomb protein SUZ12: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
F

C
T

Enhancer of zeste 2 polycomb repressive complex 2 subunit

Polycomb protein EED

Polycomb protein SUZ12

Related Entries With Identical Sequence